Abstract
A policy of selective implantation of drug eluting stents, in a minority of lesions most likely to benefit, seems to be a rational way to employ this new and currently costly technology.
| Original language | English |
|---|---|
| Pages (from-to) | 127-131 |
| Number of pages | 5 |
| Journal | Heart |
| Volume | 89 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2003 |